Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis.
Indraccolo S, De Salvo GL, Verza M, Caccese M, Esposito G, Piga I, Del Bianco P, Pizzi M, Gardiman MP, Eoli M, Rudà R, Brandes AA, Ibrahim T, Rizzato S, Lolli I, Zagonel V, Lombardi G. Indraccolo S, et al. Among authors: de salvo gl. Clin Cancer Res. 2020 Sep 1;26(17):4478-4484. doi: 10.1158/1078-0432.CCR-19-4055. Epub 2020 Jun 9. Clin Cancer Res. 2020. PMID: 32518098 Clinical Trial.
Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients.
Chiarion-Sileni V, Del Bianco P, De Salvo GL, Lo Re G, Romanini A, Labianca R, Nortilli R, Corgna E, Dalla Palma M, Lo Presti G, Ridolfi R; Italian Melanoma Intergroup (IMI). Chiarion-Sileni V, et al. Among authors: de salvo gl. Eur J Cancer. 2003 Jul;39(11):1577-85. doi: 10.1016/s0959-8049(03)00372-1. Eur J Cancer. 2003. PMID: 12855265 Clinical Trial.
Sentinel-node biopsy in breast cancer.
De Salvo GL, Del Bianco P, Zavagno G. De Salvo GL, et al. N Engl J Med. 2003 Nov 13;349(20):1968-71; author reply 1968-71. N Engl J Med. 2003. PMID: 14626250 No abstract available.
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874].
Chiarion-Sileni V, Del Bianco P, Romanini A, Guida M, Paccagnella A, Dalla Palma M, Naglieri E, Ridolfi R, Silvestri B, Michiara M, De Salvo GL. Chiarion-Sileni V, et al. Among authors: de salvo gl. BMC Cancer. 2006 Feb 27;6:44. doi: 10.1186/1471-2407-6-44. BMC Cancer. 2006. PMID: 16504154 Free PMC article. Clinical Trial.
Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL; GIVOM. Del Bianco P, et al. Among authors: de salvo gl. Eur J Surg Oncol. 2008 May;34(5):508-13. doi: 10.1016/j.ejso.2007.05.017. Epub 2007 Jul 5. Eur J Surg Oncol. 2008. PMID: 17614245 Clinical Trial.
Clinical impact of false-negative sentinel lymph nodes in breast cancer.
Zavagno G, Del Bianco P, Koussis H, Artioli G, Carraro P, De Salvo GL, Mencarelli R, Belardinelli V, Marconato G, Nitti D. Zavagno G, et al. Among authors: de salvo gl. Eur J Surg Oncol. 2008 Jun;34(6):620-5. doi: 10.1016/j.ejso.2007.07.003. Epub 2007 Aug 30. Eur J Surg Oncol. 2008. PMID: 17764888 Clinical Trial.
127 results